SCHEMBL12428229

SCHEMBL12428229

O=C(O)C1=NN(c2ccccc2)C(=O)/C1=C\C=C\c1ccc2c(c1)CCCN2Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.47
ALDH1A1 P00352 7/20 0.47
MAPT P10636 7/20 0.47
MEN1 O00255 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
HTT P42858 4/20 0.47
HPGD P15428 3/20 0.47
KDM4E B2RXH2 2/20 0.47
RECQL P46063 2/20 0.47
HKDC1 Q2TB90 1/20 0.47
L3MBTL1 Q9Y468 4/20 0.46
LMNA P02545 3/20 0.46
POLB P06746 2/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
MAPK1 P28482 5/20 0.42
MDM2 Q00987 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
TDP1 Q9NUW8 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428318 0.95 MAPT (0.42) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12510314 0.91 KMT2A (0.46) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12428124 0.90 ALDH1A1 (0.56) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12428485 0.86 KMT2A (0.42) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12428330 0.84 KMT2A (0.39) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12428321 0.84 KMT2A (0.43) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12428239 0.84 MAPT (0.43) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12428197 0.83 KMT2A (0.48) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12428220 0.83 KMT2A (0.47) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL12428219 0.83 MAPT (0.42) KMT2AALDH1A1MAPTMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 KMT2A 105/4885ALDH1A1 235/4885MAPT 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.